カルナバイオサイエンス株式会社: management transactions · Japan · EDINET (Japan FSA) EDINET:company-18867a JP JP · EDINET (Japan FSA) Mcap 8.3Bn€ Healthcare
Browse the full directors' dealings record of カルナバイオサイエンス株式会社, a publicly traded company based in Japan. Shares are quoted on JP JP, under the authority of EDINET (Japan FSA). Operating in the Healthcare sector, カルナバイオサイエンス株式会社 has logged 11 public disclosures. Market capitalisation: €8.3bn. The latest transaction was disclosed on 16 March 2023 — Holding update. Among the most active insiders: Cantor Fitzgerald & Co.. All data is free.
Financial data FY ended December 2025 · cache
Income statement
Revenue 579.1 M€
Gross profit 388.1 M€ 67% margin
Net income −2.17 Bn€ -375.0% margin
Balance sheet & cash
Market cap 8.35 Bn€
Total debt 714.5 M€
Free Cash Flow −2.17 Bn€
Profitability & ownership
ROE -243.7%
ROA -58.1%
% insiders 19.5%
% institutions 9.9%
Last declaration on 16 March 2023
Declarations 11 total
Executives ● Holding update17 EDINET
€60,643 5.6% of flow
EDINET:S100QECM · 16 Mar 2023
Executives ● Holding update17 EDINET
€70,752 6.6% of flow
EDINET:S100QDQV · 14 Mar 2023
Executives ● Holding update14 EDINET
€75,958 7.1% of flow
EDINET:S100QB0V · 27 Feb 2023
Executives ● Holding update10 EDINET
€80,801 7.5% of flow
EDINET:S100Q9SF · 20 Feb 2023
Executives ● Holding update14 EDINET
€92,563 8.6% of flow
EDINET:S100Q207 · 1 Feb 2023
Executives ● Holding update19 EDINET
€101,483 9.5% of flow
EDINET:S100Q0G4 · 24 Jan 2023
Executives ● Holding update3 EDINET
€101,483 9.5% of flow
EDINET:S100Q0DJ · 24 Jan 2023
Executives ● Holding update3 EDINET
€108,360 10.1% of flow
EDINET:S100PZBQ · 17 Jan 2023
Executives ● Holding update3 EDINET
€122,412 11.4% of flow
EDINET:S100PWAB · 28 Dec 2022
Executives ● Holding update3 EDINET
€125,414 11.7% of flow
EDINET:S100PTEQ · 16 Dec 2022
Executives ● Holding update3 EDINET
€133,522 12.4% of flow
EDINET:S100PSA2 · 12 Dec 2022